Skip to content

Icmr Will Do Clinical Trial Of Corona Therepy Collaboration With Oxford University

PTI, Delhi

Published by: Jeet Kumar
Updated Sat, 10 Jul 2021 12:28 AM IST

Table Of Contents hide

abstract

ICMR said that ICMR Delhi, in collaboration with Oxford University, is planning to conduct clinical trials of COVID-19 patients through an adaptive platform at multiple centers

hear the news

The Indian Council of Medical Research (ICMR) is working with Oxford University on a plan to conduct clinical trials for ‘evaluation of COVID-19 therapy’. For this, permission has been sought from hospitals to participate in clinical trials.

Giving this information on Friday, ICMR said that the clinical trial – ‘India-UK Recovery (Evaluation of Kovid-19 Therapy)’ will be conducted on Kovid patients of several centers and conditions will be favorable for this.

ICMR said that ICMR Delhi, in collaboration with Oxford University, is planning to conduct clinical trials of COVID-19 patients at multiple centers through an adaptive platform titled ‘India-UK Recovery (Randomized Evaluation of COVID-19 Therapy)’ is.

This has been discussed with the institutions/hospitals with facilities and capacity available to participate in the clinical trial and the COVID-19 patients admitted there will participate.

Detailed

The Indian Council of Medical Research (ICMR) is working with Oxford University on a plan to conduct clinical trials for ‘evaluation of COVID-19 therapy’. For this, permission has been sought from hospitals to participate in clinical trials.

Giving this information on Friday, ICMR said that the clinical trial – ‘India-UK Recovery (Evaluation of Kovid-19 Therapy)’ will be conducted on Kovid patients of several centers and conditions will be favorable for this.

ICMR said that ICMR Delhi, in collaboration with Oxford University, is planning to conduct clinical trials of COVID-19 patients at multiple centers through an adaptive platform titled ‘India-UK Recovery (Randomized Evaluation of COVID-19 Therapy)’ is.

This has been discussed with the institutions/hospitals with facilities and capacity available to participate in the clinical trial and the COVID-19 patients admitted there will participate.

Leave a Reply

Your email address will not be published.